Killer cell Ig-like receptor (KIR) 3DL1 down-regulation enhances inhibition of type 1 diabetes by autoantigen-specific regulatory T cells

• DOI: 10.1073/pnas.1019082108
• Publication Date: 2011-01-19T05:04:46Z
• Authors: Hanjun Qin; Zunde Wang; Weiting Du; Wen-Hui Lee; Xiwei Wu; Arthur D. Riggs; Chih-Pin Liu
• Keywords: Mice; 0303 health sciences; 03 medical and health sciences; Diabetes Mellitus, Type 1; Receptors, KIR; Mice, Inbred NOD; Gene Knockdown Techniques; Animals; Down-Regulation; Autoantigens; T-Lymphocytes, Regulatory; 3. Good health

Both Foxp3+regulatory T cells (Tregs) and antigen-expanded Foxp3−Tregs play an important role in regulating immune responses as well as in preventing autoimmune diseases and graft rejection. Molecular mechanisms modulating Treg function remain largely unclear, however. We report here on the expression and function of an inhibitory killer cell Ig-like receptor, KIR3DL1, in a nonobese diabetic (NOD) mouse-derived autoantigen-specific Treg (2D2), which protects from type 1 diabetes (T1D) in adoptive transfer experiments. This gene is not expressed in T1D pathogenic T cells (Tpaths) or non-Tpath T cells. KIR genes are known to play an important role in regulating natural killer (NK) cell function, but their role in Tregs and T1D is unknown. To examine whether KIR3DL1 expression may modulate Treg function, we used shRNA to down-regulate KIR3DL1 expression (2D2-shKIR). We find that KIR3DL1 down-regulation enhances in vitro function, as measured by improved suppression of target cell proliferation. Antibody blockade of IL-10 but not IL-4 partially abrogated suppressive function. In vivo function is also improved. Adoptive transfer of 2D2-shKIR into 10-wk-old NOD mice prevented spontaneous insulitis and T1D, and the inhibitory effect was further improved if the cells were transferred earlier into 6-wk-old NOD mice. These studies indicate that KIR3DL1 expression may negatively regulate Treg function and suggest a previously undescribed target for improving immune tolerance for potential treatment of autoimmune diseases like T1D.